International Patient Organisation Treatment Action Group sent a letter to the Prime Minister of Ukraine, where the concerns are expressed towards the policy of Valartin Pharma, which is a national manufacturer of the drug for the treatment of hepatitis C. The main issues raised in the letter are not transparent drug registration, ignoring open dialogue with the Ukrainian patient environment on product quality and patient jrganizations attack in media.
